ClinicalTrials.govpublic full text
Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon
chronic hepatitis c, hcv genotype 2 (gt-2), hcv genotype 3 (gt-3), hcv, sustained virologic response, direct acting antiviral, combination therapy, interferon intolerant, interferon ineligible, gs-7977, ribavirin, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 841127
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.